[1] Cohen J,Chabbert-Buffet N,Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder—a plea for universal definitions[J]. J Assist Reprod Genet,2015,32(12):1709-1712.
[2] HowardAnderson J,Ganz PA,Bower JE,et al. Quality of life,fertility concerns,and behavioral health outcomes in younger breast cancer survivors: a systematic review[J]. J Natl Cancer Inst,2012,104 (5):386-405.
[3] Yeh J,Kim B,Liang YJ,et al. Müllerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage[J]. Biochem Biophys Res Commun,2006,348(2):337-344.
[4] Liang D,Cao BL,Li JK,et al. Experimental study of cisplatin inducement in establishment of the rat model of premature ovarian failure [J]. Modern Journal of Integrated Traditional Chinese and Western Medicine,2012,21(26):2873-2875. (in Chinese)
梁丹,曹保利,李继坤,等. 顺铂诱导大鼠卵巢早衰的实验研究[J]. 现代中西医结合杂志,2012,21(26):2873-2875..
[5] Li Dong,Chen Yan,Qi, Lei,et al. Differentially expressed genes in cisplatin-induced premature ovarian failure in rats[J]. Anim Reprod Sci,2013,137(3-4):205-213.
[6] Jurisicova A,Lee HJ,D’Estaing SG,et al.Molecular requirements for doxorubicin-mediated death in murine oocytes[J]. Cell Death Differ,2006,13(9):1466-1474.
[7] Ben-Aharon Ⅰ,Shalgi R. What lies behind chemotherapy-induced ovarian toxicity[J]? Reproduction,2012,144 (2):153-163.
[8] Hasky N,Uri-Belapolsky S,Goldberg K,et al. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma[J]?Hum Reprod,2015,30 (5):1089-1101.
[9] Ben-Aharon Ⅰ,Bar-Joseph H,Tzarfaty G, et al. Doxorubicin-induced ovarian toxicity[J]. Reprod Biol Endocrinol,2010,8(20):2-7.
[10] Morgan S,Anderson RA,Gourley C,et al. How do chemotherapeutic agents damage the ovary[J]? Hum Reprod Update,2012,18(5):525-535.
[11] Oktem O,Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function[J]. Cancer, 2007,110(10):2222-2229.
[12] Xu PL, Liu JM,Derynck R. Post-translational regulation of TGF-beta receptor and Smad signaling[J]. FEBS Lett,2012,586(14):1871-1884.
[13] Pardali E,Goumans MJ,ten Dijke P. Signaling by members of the TGFbeta family in vascular morphogenesis and disease[J]. Trends Cell Biol,2010,20(9):556-567.
[14] Massague J. TGFbeta signalling in context[J]. Nat Rev Mol Cell Biol,2012,13(10):616-630.
[15] Massague J, Gomis RR. The logic of TGFbeta signaling[J]. FEBS Lett, 2006,580(12):2811-2820.
[16] Tomic D,Miller KP,Kenny HA,et al. Ovarian follicle development requires Smad3[J]. Mol Endocrinol,2004,18(9):2224-2240.
[17] Li Q,Pangas SA,Jorgez CJ,et al. Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo[J]. Mol Cell Biol,2008,28(23):7001-7011.
[18] Wei XH,Qi LH,Chi XCh, et al. The effects of FSH on the phosphorylation of Smad2/Smad3 protein in rat ovarian granulose cells [J]. Acta Anatomica Sinica,2007,38(2):205-208. (in Chinese)
卫晓红,祁丽花,迟晓春,等. Smad2/Smad3 蛋白在大鼠卵巢颗粒细胞中的表达及 FSH 对其活化的影响[J]. 解剖学报,2007,38(2):205-208.
[19] Li J,Tang X,Chen X. Comparative effects of TGF-β2/Smad2 and TGF-β2/Smad3 signaling pathways on proliferation, migration, and extracellular matrix production in a human lens cell line[J]. Exp Eye Res, 2011, 92(3): 173-179.
|